239087-05-9 Usage
Uses
Used in Pharmaceutical Industry:
2-Fluoro-4-(trifluoromethyl)benzylamine is used as a key intermediate for the synthesis of pharmaceutical drugs due to its ability to enhance the properties of the final drug products, such as potency, selectivity, and bioavailability.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Fluoro-4-(trifluoromethyl)benzylamine is utilized as a building block for the development of new agrochemicals, contributing to improved crop protection and yield enhancement.
Used in Chemical Industry:
2-FLUORO-4-(TRIFLUOROMETHYL)BENZYLAMINE is employed as a versatile building block in the manufacturing of specialty chemicals, where its unique properties can be leveraged to create novel chemical entities with specific applications.
Used in Medicinal Chemistry:
2-Fluoro-4-(trifluoromethyl)benzylamine is used as a synthetic intermediate in medicinal chemistry for the development of new therapeutic agents, potentially leading to the discovery of innovative treatments for various diseases.
Used in Material Science:
In the field of material science, 2-FLUORO-4-(TRIFLUOROMETHYL)BENZYLAMINE is utilized for the synthesis of new materials with unique properties, such as improved stability, reactivity, or selectivity, which can be applied in various industrial processes.
Check Digit Verification of cas no
The CAS Registry Mumber 239087-05-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,9,0,8 and 7 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 239087-05:
(8*2)+(7*3)+(6*9)+(5*0)+(4*8)+(3*7)+(2*0)+(1*5)=149
149 % 10 = 9
So 239087-05-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H7F4N/c9-7-3-6(8(10,11)12)2-1-5(7)4-13/h1-3H,4,13H2
239087-05-9Relevant articles and documents
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
-
, (2008/06/13)
Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity, wherein X1, X2, X3, X4, X5, R5, R6, R7, R8a, R8b, R9, Z1, Z2 and L are as defined in the description.
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
-
Page/Page column 67, (2010/02/11)
Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
-
, (2008/06/13)
Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
